Dogwood Therapeutics, Inc. (DWTX) — Cash & Equivalents
| Fiscal Year | Cash & Equivalents | Change YoY |
|---|---|---|
| 2025 | $6.52M | -56.1% |
| 2024 | $14.85M | +347.6% |
| 2023 | $3.32M | -52.8% |
| 2022 | $7.03M | -49.8% |
| 2021 | $14.01M | -53.0% |
| 2020 | $29.80M | — |
| Fiscal Year | Cash & Equivalents | Change YoY |
|---|---|---|
| 2025 | $6.52M | -56.1% |
| 2024 | $14.85M | +347.6% |
| 2023 | $3.32M | -52.8% |
| 2022 | $7.03M | -49.8% |
| 2021 | $14.01M | -53.0% |
| 2020 | $29.80M | — |